Increasing SARS-CoV-2 seroprevalence among UK pediatric patients on dialysis and kidney transplantation between January 2020 and August 2021.

Background : Coronavirus disease 2019 (COVID-19) was officially declared a pandemic by the World Health Organisation (WHO) on 11 March 2020, as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread rapidly across the world. We investigated the seroprevalence of anti-SARS-CoV-2 antibodi...

Descripción completa

Detalles Bibliográficos
Publicado en:Pediatric Nephrology Vol. 38; no. 11; pp. 3745 - 3756
Autores principales: Bamber, Holly N., Kim, Jon Jin, Reynolds, Ben C., Afzaal, Javairiya, Lunn, Andrew J., Tighe, Patrick J., Irving, William L., Tarr, Alexander W.
Formato: research tables/charts Journal Article
Publicado: Springer Nature Nov2023
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=172285010&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 172285010
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        0931041X
        EF1
      jtl: Pediatric Nephrology
      issn: 0931041X
      maglogo: N
    pubinfo:
      dt: Nov2023
      vid: 38
      iid: 11
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        172285010
        164030322
        172285010
        172285010
        10.1007/s00467-023-05983-1
        172285010
      ppf: 3745
      ppct: 11
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Increasing SARS-CoV-2 seroprevalence among UK pediatric patients on dialysis and kidney transplantation between January 2020 and August 2021.
      aug:
        au:
          Bamber, Holly N.
          Kim, Jon Jin
          Reynolds, Ben C.
          Afzaal, Javairiya
          Lunn, Andrew J.
          Tighe, Patrick J.
          Irving, William L.
          Tarr, Alexander W.
        affil: https://ror.org/01ee9ar58 School of Life Sciences, University of Nottingham, Nottingham, UK
      sug:
        subj:
          COVID-19 United Kingdom
          Seroprevalence Studies
          Dialysis Patients In Infancy and Childhood
          Kidney Transplantation
          Transplant Recipients In Infancy and Childhood
          Peritoneal Dialysis
          Hemodialysis
          Human
          Male
          Female
          Child
          Adolescence
          United Kingdom
          Stay-at-Home Orders
          Social Distancing
          Renal Replacement Therapy
          Antibodies
          Cross Sectional Studies
          Funding Source
          Child: 6-12 years
          Adolescent: 13-18 years
          Male
          Female
      ab: Background : Coronavirus disease 2019 (COVID-19) was officially declared a pandemic by the World Health Organisation (WHO) on 11 March 2020, as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread rapidly across the world. We investigated the seroprevalence of anti-SARS-CoV-2 antibodies in pediatric patients on dialysis or kidney transplantation in the UK. Methods: Excess sera samples were obtained prospectively during outpatient visits or haemodialysis sessions and analysed using a custom immunoassay calibrated with population age-matched healthy controls. Two large pediatric centres contributed samples. Results: In total, 520 sera from 145 patients (16 peritoneal dialysis, 16 haemodialysis, 113 transplantation) were analysed cross-sectionally from January 2020 until August 2021. No anti-SARS-CoV-2 antibody positive samples were detected in 2020 when lockdown and enhanced social distancing measures were enacted. Thereafter, the proportion of positive samples increased from 5% (January 2021) to 32% (August 2021) following the emergence of the Alpha variant. Taking all patients, 32/145 (22%) were seropositive, including 8/32 (25%) with prior laboratory-confirmed SARS-CoV-2 infection and 12/32 (38%) post-vaccination (one of whom was also infected after vaccination). The remaining 13 (41%) seropositive patients had no known stimulus, representing subclinical cases. Antibody binding signals were comparable across patient ages and dialysis versus transplantation and highest against full-length spike protein versus spike subunit-1 and nucleocapsid protein. Conclusions: Anti-SARS-CoV-2 seroprevalence was low in 2020 and increased in early 2021. Serological surveillance complements nucleic acid detection and antigen testing to build a greater picture of the epidemiology of COVID-19 and is therefore important to guide public health responses.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N